Opinion
24-49-KSM
09-06-2024
IN RE REGENERON PHARMACEUTICALS, INC.
ORDER
KAREN SPENCER MARSTON, J.
AND NOW, this 6th day of September 2024, upon consideration of Regeneron Pharmaceuticals, Inc.'s (“Regeneron”) Ex Parte Application for an Order Pursuant to 28 U.S.C. § 1782 (Doc. No. 1) and for the reasons set forth in the accompanying Memorandum, it is ORDERED that the Application (Doc. No. 1) is GRANTED. Regeneron is granted leave to serve the subpoenas attached as Exhibits A and B to the Application (Doc. Nos. 1-1, 1-2), directing Sharp Packaging Services, LLC (“Sharp”) to produce the documents and provide the testimony requested in the subpoenas pursuant to Federal Rule of Civil Procedure 45.
IT IS FURTHER ORDERED that Regeneron shall serve a copy of its Application and related materials (Doc. No. 1), this Court's Memorandum, and this Order on Sharp.
IT IS SO ORDERED.